We are live on ! Find out more
NPCE icon

Neuropace
NPCE

44 hedge funds and large institutions have $259M invested in Neuropace in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.9% more ownership

Funds ownership: 0% → 44.9% (+45%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$93.1M
2
SCM
Soleus Capital Management
Connecticut
+$32.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.6M
4
BG
Bellevue Group
Switzerland
+$11.8M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$11.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$95.5M +$93.1M +4,012,281 New
SCM
2
Soleus Capital Management
Connecticut
$32.9M +$32.1M +1,384,387 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$25.2M +$24.6M +1,060,059 New
BG
4
Bellevue Group
Switzerland
$12.1M +$11.8M +507,930 New
PAMU
5
Pictet Asset Management (UK)
United Kingdom
$11.6M +$11.3M +485,964 New
SAM
6
Sectoral Asset Management
Quebec, Canada
$11.2M +$11M +471,966 New
KCM
7
Kornitzer Capital Management
Kansas
$10.8M +$10.5M +453,012 New
American Century Companies
8
American Century Companies
Missouri
$9.58M +$9.35M +402,754 New
BlackRock
9
BlackRock
New York
$7.96M +$7.76M +334,495 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.95M +$6.78M +291,976 New
Millennium Management
11
Millennium Management
New York
$6.05M +$5.9M +254,238 New
Lord, Abbett & Co
12
Lord, Abbett & Co
New Jersey
$5.88M +$5.74M +247,368 New
PVI
13
Pura Vida Investments
New York
$5.45M +$5.32M +229,264 New
NCM
14
Nantahala Capital Management
Connecticut
$3.51M +$3.42M +147,404 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.64M +$2.58M +110,980 New
State Street
16
State Street
Massachusetts
$1.73M +$1.69M +72,806 New
Northern Trust
17
Northern Trust
Illinois
$1.7M +$1.65M +71,277 New
Norges Bank
18
Norges Bank
Norway
$1.38M +$1.35M +58,000 New
JJIJ
19
Johnson & Johnson Innovation - JJDC
New Jersey
$1.32M +$1.29M +55,435 New
GCM
20
Ghisallo Capital Management
Massachusetts
$1.19M +$1.16M +49,999 New
APM
21
Avidity Partners Management
Texas
$952K +$928K +40,000 New
CCM
22
CAAS Capital Management
New York
$952K +$928K +40,000 New
Charles Schwab
23
Charles Schwab
California
$416K +$405K +17,448 New
Marshall Wace
24
Marshall Wace
United Kingdom
$355K +$347K +14,939 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$274K +$267K +11,499 New
1
2

NPCE Hedge Fund Activity: Q2 2021 in Review

44 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q2 2021, worth a combined $259M.

Buyers outnumbered sellers: 44 funds opened new NPCE positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $93.1M.

  • 44 institutional investors held Neuropace (NPCE) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $259M of Neuropace stock for Q2 2021.
  • 44 funds opened new Neuropace positions in Q2 2021 and 0 closed out, a net change of +44 holders.
  • The largest Neuropace buyer in Q2 2021 was OrbiMed, an estimated $93.1M added.

Based on aggregated 13F filings for Q2 2021.